New 52-week high$242.08+2.4% vs prior high · 2026-10-15
Moderna just set a fresh 52-week high at $242.08, 2.36% above the peak it reached on October 15. A year ago the stock traded near $27.
Latest Activity
Gainers
Losers
General Motors shed 7.5% into the close, the worst showing across 387 priority names and nearly double the next-biggest decline. GoPro and Clover Health anchored the other end, each up more than 7.5%.
Gainers
Losers
GoPro's 10.3% jump leads the open, with Moderna close behind and the entire downside capped under 3.5%. Across the priority names, the gains are doing all the work this morning.
54stocks hit new 52-week highs this week
- MRNAModerna$218.01+16.2%
- BOXBox$39.56+8.9%
- SUSuncor Energy$78.05+8.6%
- BPBP p.l.c.$50.21+6.9%
- SHELShell$106.66+6.5%
- DOCUDocuSign$74.65+6.0%
- PSXPhillips 66$293.17+5.6%
- PBRPetrobras$26+5.3%
- PBR-APetrobras$23.3+5.2%
- XOMExxon Mobil$178.98+5.1%
54 stocks printed fresh 52-week highs this week, and Big Oil showed up in force: Suncor, BP, Shell, Phillips 66, Petrobras and Exxon all cleared prior peaks. Moderna led the whole list, topping its old high by 16%.
Gainers
Losers
Every one of today's five worst performers in a 383-name universe lost double digits, led by CoreWeave's 15.42% drop. The best gain on the other side was capped at 4.62%, so the downside is moving far faster than the upside.
36stocks hit new 52-week highs this week
- PBRPetrobras$25.3+16.2%
- PEverpure$154.49+15.2%
- PBR-APetrobras$22.47+14.8%
- HPEHewlett Packard Enterprise$73.46+13.8%
- MRNAModerna$225+10.6%
- MPCMarathon Petroleum$455.03+9.1%
- FTNTFortinet$194.75+8.9%
- RBRKRubrik$125.14+8.8%
- ITUBItau Unibanco$10.16+8.4%
- GTLBGitLab$55.09+7.9%
36 stocks set fresh 52-week highs this week, with Petrobras clearing its old peak by 16%. Hewlett Packard Enterprise, Moderna, Marathon Petroleum, Fortinet, Rubrik and GitLab round out the breakout list.
After-hours
$225.00
+12.56%open $199.89
A 12.6% run to $225 piles roughly $11 billion onto Moderna's $89.8 billion market value in a single session, a move of a size this name rarely posts. Keep an eye on whether the gain holds through the after-hours tape.
Gainers
Losers
All three major US wireless carriers closed down double digits on the same day, a rare sweep for names usually bought as defensive income. Moderna's 13.8% gain topped the board on the other side.
Reddit Pulser/wallstreetbets
70k to 1.2M. Living the dream
A $70,000 bet turned into roughly $1.2 million, and the trader is rotating out instead of riding it. The hardest part of a concentrated winner is deciding when to cut the position down.
Gainers
Losers
Spotify closed the session's best performer at 5.24%, taking the stock to $513.73. GoPro, MicroStrategy, Iren, Applied Optoelectronics and Lucid all shed more than 6%.
MRNA Coverage
1:53pm ET
Investing
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
Moderna‘s (NASDAQ:MRNA | MRNA Price Prediction) push into cancer treatment is drawing heavy buying as a closely followed melanoma presentation approaches. Shares of Moderna are up 7% to $241.89 during the trading…
12:44pm ET
Investing
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Vaccine stocks are under heavy pressure, and the smallest name in the group is taking the heaviest losses. Novavax (NASDAQ:NVAX) stock is down 12% to $11.23 in afternoon trading, leading the slide…
10:49am ET
Investing
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the furthest. Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is down 10%…
12:55pm ET
Investing
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA (mRNA) name is pulling well ahead of the pack. Moderna (NASDAQ:MRNA | MRNA…
8:20am ET
Investing
Moderna Stock Is Soaring on Cancer Vaccine Buzz. Is It Too Late to Get In?
Moderna has surged more than 650% this year on cancer vaccine excitement, but analyst targets sit far below the current share price. Before you chase the rally, there are some uncomfortable numbers…
1:59pm ET
Investing
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
A protein-vaccine developer with no fresh catalyst just posted a double-digit gain that dwarfs what Moderna and Merck managed in the same session, and the explanation reveals something uncomfortable about how this…
11:48am ET
Investing
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock trades at $207.80, up 5%, after its addition to the NASDAQ 100 took effect. That entry places a company once valued as a COVID-19 vaccine…
7:30am ET
Investing
3 Stocks That Have More Than Doubled the S&P 500’s Return This Year
Three stocks left the S&P 500's 2025 return in the dust, but gains that large raise one uncomfortable question: is the opportunity already gone, or does one of them still have a…
3:03pm ET
Investing
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
Moderna stock has turned a handful of patient shareholders into believers, but a gain this size forces a choice that most investors never plan for in advance. The pipeline promise is real,…
9:56am ET
Investing
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna and Pfizer Inch Higher
A plague headline out of Siberia lifted vaccine stocks, and the agencies closest to the case have since described the risk as low. That reversal in sentiment lands hardest on Novavax (NASDAQ:NVAX),…
9:10am ET
Investing
The $110 Billion Paramount-Warner Merger Closes Today. What Shareholders Need to Know
One group of shareholders walks away with cash at closing. The other inherits a renamed company on a new exchange carrying roughly $80 billion in debt, and the settlement terms make the…
3:02pm ET
Investing
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up
Sanofi just handed Novavax a commercial lifeline for the fall vaccination season, and the stock is reacting in a way that leaves Moderna and BioNTech looking like bystanders. The real question is…
2:47pm ET
Investing
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are trading as though the company’s messenger RNA (mRNA) cancer vaccine has already cleared its final test, even though the complete Phase 3 dataset…
11:00am ET
Investing
Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
Buyers are stepping into Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares, evidently. The move comes one session after a Citigroup (NYSE:C) downgrade to Sell, a sign the market still prizes the company’s…
9:42am ET
Investing
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is drawing attention Wednesday after Citigroup downgraded the biotech company to Sell from Hold, arguing that the recent rally has pushed the valuation well ahead…